American International Group, Inc. Travere Therapeutics, Inc. Transaction History

American International Group, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$7.18 - $9.82 $2,211 - $3,024	-308 Reduced 0.85%	35,901 $276,000
Q4 2023 Feb 13, 2024	SELL	$5.44 - $9.5 $799 - $1,396	-147 Reduced 0.4%	36,209 $325,000
Q3 2023 Nov 13, 2023	BUY	$7.64 - $17.25 $9,878 - $22,304	1,293 Added 3.69%	36,356 $325,000
Q2 2023 Aug 04, 2023	BUY	$15.3 - $22.61 $82,084 - $121,302	5,365 Added 18.07%	35,063 $538,000
Q1 2023 May 12, 2023	BUY	$17.82 - $22.89 $10,531 - $13,527	591 Added 2.03%	29,698 $667,000
Q4 2022 Feb 10, 2023	BUY	$18.47 - $26.14 $3,583 - $5,071	194 Added 0.67%	29,107 $612,000
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $9,347 - $11,681	408 Added 1.43%	28,913 $712,000
Q2 2022 Aug 12, 2022	SELL	$20.94 - $30.01 $16,877 - $24,188	-806 Reduced 2.75%	28,505 $691,000
Q1 2022 May 13, 2022	SELL	$23.61 - $30.6 $48,731 - $63,158	-2,064 Reduced 6.58%	29,311 $755,000
Q4 2021 Feb 11, 2022	SELL	$24.34 - $31.17 $12,948 - $16,582	-532 Reduced 1.67%	31,375 $974,000
Q3 2021 Nov 12, 2021	SELL	$12.98 - $25.03 $9,838 - $18,972	-758 Reduced 2.32%	31,907 $774,000
Q2 2021 Aug 13, 2021	BUY	$14.11 - $26.4 $5,883 - $11,008	417 Added 1.29%	32,665 $477,000
Q1 2021 May 07, 2021	BUY	$23.37 - $31.77 $89,016 - $121,011	3,809 Added 13.39%	32,248 $805,000
Q4 2020 Feb 12, 2021	BUY	$19.17 - $27.87 $545,175 - $792,594	28,439 New	28,439 $775,000

184

89.8M

137K

181K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $898M
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.